<table style="border:1px solid #adadad; background-color: #F3F1EC; color: #666666; padding:8px; -webkit-border-radius:4px; border-radius:4px; -moz-border-radius:4px; line-height:16px; margin-bottom:6px;" width="100%">
        <tbody>
                <tr>
                        <td><span style="font-family:Helvetica, sans-serif; font-size:20px;font-weight:bold;">Mind & Brain News -- ScienceDaily</span></td>
                </tr>
                <tr>
                        <td> </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="https://www.sciencedaily.com/releases/2025/07/250706081848.htm" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">Cough medicine turned brain protector? Ambroxol may slow Parkinson’s dementia</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Jul 6th 2025, 09:01</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p>Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes even saw cognitive gains, hinting at real disease-modifying power.</p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="https://www.sciencedaily.com/releases/2025/07/250705084325.htm" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">Multisensory VR forest reboots your brain and lifts mood—study confirms</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Jul 6th 2025, 08:17</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p>Immersing stressed volunteers in a 360° virtual Douglas-fir forest complete with sights, sounds and scents boosted their mood, sharpened short-term memory and deepened their feeling of nature-connectedness—especially when all three senses were engaged. Researchers suggest such multisensory VR “forest baths” could brighten clinics, waiting rooms and dense city spaces, offering a potent mental refresh where real greenery is scarce.</p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<table style="font:13px Helvetica, sans-serif; border-radius:4px; -moz-border-radius:4px; -webkit-border-radius:4px; background-color:#fff; padding:8px; margin-bottom:6px; border:1px solid #adadad;" width="100%">
        <tbody>
                <tr>
                        <td><a href="https://www.sciencedaily.com/releases/2025/07/250705083956.htm" style="font-family:Helvetica, sans-serif; letter-spacing:-1px;margin:0;padding:0 0 2px;font-weight: bold;font-size: 19px;line-height: 20px;color:#222;">Scientists reverse Parkinson’s symptoms in mice — Could humans be next?</a>
                        <div style="font-family:Helvetica, sans-serif; text-align:left;color:#999;font-size:11px;font-weight:bold;line-height:15px;">Jul 5th 2025, 23:13</div>

                        <div style="font-family:Helvetica, sans-serif; color:#494949;text-align:justify;font-size:13px;">
                        <p>Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain cells and fuels Parkinson’s disease. In mouse models, restoring the protein’s function with a targeted copper supplement dramatically rescued movement, hinting at a future therapy that could slow or halt the disease in people.</p>
                        </div>

                        <div style="font-family:Helvetica, sans-serif; font-size:13px; text-align: center; color: #666666; padding:4px; margin-bottom:2px;"></div>
                        </td>
                </tr>
        </tbody>
</table>
<p><strong>Forwarded by:<br />
Michael Reeder LCPC<br />
Baltimore, MD</strong></p>

<p><strong>This information is taken from free public RSS feeds published by each organization for the purpose of public distribution. Readers are linked back to the article content on each organization's website. This email is an unaffiliated unofficial redistribution of this freely provided content from the publishers. </strong></p>

<p> </p>

<p><s><small><a href="#" style="color:#ffffff;"><a href='https://blogtrottr.com/unsubscribe/565/QbcxgL'>unsubscribe from this feed</a></a></small></s></p>